Genentech eyes lupus market for Gazyva with positive Phase III data readout

Retrieved on: 2025-02-07 12:52:47

Tags for this article:

Click the tags to see associated articles and topics

Genentech eyes lupus market for Gazyva with positive Phase III data readout. View article details on hiswai:

Excerpt

Roche's subsidiary Genentech has shared positive Phase III data with the US Food and Drug Administration (FDA) as the company targets the billion ...

Article found on: www.clinicaltrialsarena.com